​Intra-Cellular Therapies appoints chief compliance officer

Intra-Cellular Therapies, a biopharmaceutical company, has appointed Karen Sheehy as chief compliance officer.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.